Clinical Trial Update: A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT) [Phase 3]

View source ↗

Summary

A Phase 3 head-to-head trial comparing Travoprost 0.004% with Latanoprost 0.005% in open-angle glaucoma and ocular hypertension has completed, evaluating safety…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma Open-angle
• Ocular Hypertension

Drugs mentioned

• TRAVATAN Z (TRAVOPROST)
• Xalatan (latanoprost)

Snippet

Sponsor: Alcon Research | Conditions: Glaucoma, Open-Angle, Ocular Hypertension | Phase 3 | Status: COMPLETED